Coriell Institute for Medical Research
Coriell Institute of Medical Research
  • Request a Quote
  • Donate
  • Login
  • View Cart
Sample Catalog | Custom Services | Core Facilities | Genomic Data Search
  • Biobank
    • NIGMS
    • NINDS
    • NIA
    • NHGRI
    • NEI
    • Allen Cell Collection
    • Rett Syndrome iPSC Collection
    • Autism Research Resource
    • HD Community Biorepository
    • CDC Cell and DNA
    • J. Craig Venter Institute
    • Orphan Disease Center Collection
    • All Biobanks
  • Research
    • Overview
    • Meet Our Scientists
      • Our Faculty
      • Our Scientific Staff
    • Camden Cancer Research Center
    • Epigenetic Therapies SPORE
    • Core Facilities
    • Epigenomics
    • Camden Opioid Research Initiative (CORI)
    • The Issa & Jelinek Lab
    • The Jian Huang Lab
    • The Luke Chen Lab
      • The Lab
      • The Team
      • Publications
    • The Scheinfeldt Lab
    • The Shumei Song Lab
    • The Nora Engel Lab
      • The Lab
      • The Team
      • Publications
    • Publications
  • Services
    • Overview
    • Biobanking Services
      • Core Services
      • Project Management
      • Research Support Services
      • Sample Cataloging
      • Sample Collection Kits
      • Sample Data Management
      • Sample Distribution
      • Sample Management
      • Sample Procurement
      • Sample Storage
    • Bioinformatics and Biostatistics Services
    • Cellular and Molecular Services
      • Biomarker Research Solutions
      • Cell Culture
      • Nucleic Acid Isolation and Quality Control
    • Clinical Trial Support
      • Overview
      • Sample Collection
      • Data Management
      • Sample Processing and QC
      • Storage and Distribution
      • Biomarker Services
      • Data Analaysis
    • Core Facilties
      • Overview
      • Animal and Xenograft
      • Bioinformatics and Biostatistics
      • Cell Imaging
      • CRISPR Gene Engineering
      • Flow Cytometry and Cell Sorting
      • Genomics and Epigenomics
      • iPSC - Induced Pluripotent Stem Cells
      • Organoids
    • Coriell Marketplace
    • Genomic, Epigenomic and Multiomics Services
    • Stem Cells and iPSC Services
      • Core Services
      • Reprogramming
      • Characterization and Quality Control
      • Differentiated Cell Lines
      • iPSC-Derived Organoids
      • iPSC Expansion
      • iPSC Gene Editing
  • Ordering
    • Stem Cells
    • Cell Lines
    • DNA and RNA
    • Featured Products
      • FFPE
      • HMW DNA
    • Genomic Data Search
    • Search by Catalog ID
    • Help
      • Create Account
      • Order Online
      • Ordering FAQ
      • FAQs/Culture Instructions
      • Reference Materials
        • Biobanks
        • NIGMS Repository
        • NHGRI Repository
        • NINDS Repository
        • NIA Repository
        • NIST
        • GeT-RM
      • Secondary Distribution Policies
      • MTA Assurance Form
      • Shipment Policy
      • Contact Customer Service
  • About Us
    • Our History
    • Meet Our Team
    • Meet Our Board
    • Education
      • Science Fair
      • Summer Experience
      • Outreach
      • Research Program Internship
    • Press Room
      • Press Releases
      • Coriell Blog
      • Annual Report
    • Careers
      • Working at Coriell
    • Giving
      • Donate
      • Giving FAQ
    • Contact Us
    • Legal Notice
  • Login View Cart
search submit
GM02094 Fibroblast

Description:

SANDHOFF DISEASE
HEXOSAMINIDASE B; HEXB

Affected:

Yes

Sex:

Male

Age:

12 YR (At Sampling)

  • Overview
  • Characterizations
  • Phenotypic Data
  • Publications
  • External Links
  • Culture Protocols

Overview

back to top
Repository NIGMS Human Genetic Cell Repository
Subcollection Heritable Diseases
Lysosomal Storage Diseases
Class Disorders of Lipid Metabolism
Cell Type Fibroblast
Transformant Untransformed
Race White
Family Member 1
Relation to Proband proband
Confirmation Clinical summary/Case history
Species Homo sapiens
Common Name Human
Remarks Juvenile; cerebellar ataxia; severe mental retardation; deficient hexosaminidase A and B; same patient as GM02144; normal level of fibro preBchain mRNA; 3% of normal fibro Hex A activity; Hex B gene shows no gross abnormalities; point mutation in 1 beta-chain allele (c.1509-26G>A), resulting in an a 24-base insertion between exons 12 and 13 in cDNA. Mutation in the other allele is unknown.

Characterizations

back to top
PDL at Freeze 5.19
Passage Frozen 5
 
IDENTIFICATION OF SPECIES OF ORIGIN Species of Origin Confirmed by Nucleoside Phosphorylase Isoenzyme Electrophoresis
 
MUTATION VERIFICATION Nakano and Suzuki (J Biol Chem 264:5155-5158 1989) reported the sequence analysis of a cDNA clone isolated from the fibroblasts of this Sandhoff disease patient. They found an extra 24 base segment between exons 12 and 13. This segment was identified as the 3 prime terminus of intron 12. The remainder of the coding sequence was completely normal. This insertion is inframe and adds 8 amino acids between amino acids 491 and 492 of the primary sequence of the normal B-hexosaminidase B chain protein. The finding is consistent with the slightly larger than normal size of the B subunit precursor protein observed by immunoprecipitation. No normally spliced mRNA was detected. Gene amplification and subsequent sequencing of genomic DNA indicated that the patient was a compound heterozygote. In one allele there was a single nucleotide transition from normal G to A at 26 bases from the 3 prime terminus of intron 12. This mutation generates a consensus sethe abnormal mRNAs that retain 24 bases of the 3 prime terminus of intron 12. The intron 12 and flanking exons 12 and 13 sequences were normal in the other allele. The authors believe that the other mutant allele is therefore likely to be of an mRNA-negative type.
 
beta-N-acetylhexosaminidase (hexosaminidase A) According to the submitter, biochemical test results for this subject showed decreased enzyme activity. EC Number: 3.2.1.52; 3% activity.
 
beta-N-acetylhexosaminidase (hexosaminidase B) According to the submitter, biochemical test results for this subject showed decreased enzyme activity. EC Number: 3.2.1.52
 
Gene HEXB
Chromosomal Location 5q13
Allelic Variant 1 268800.0002; SANDHOFF DISEASE, JUVENILE TYPE
Identified Mutation 24-BP INS; In a case of the juvenile form reported by Wood and MacDougall (1976), Nakano and Suzuki (1989) showed that a cDNA clone isolated from fibroblasts contained an extra 24-base segment between exons 12 and 13. This segment was identified as the 3-prime terminus of intron 12. The remainder of the coding sequence was completely normal. The insertion was 'in frame' and added 8 amino acids between amino acids 491 and 492 of the enzyme protein. It was located only 5 amino acids away from a possible glycosylation site. Gene amplification by the PCR and subsequent sequencing of genomic DNA showed that the patient was a compound heterozygote. In 1 allele there was a single nucleotide transition from normal G to A at 26 bases from the 3-prime terminus of intron 12. This mutation generated a consensus sequence for the 3-prime splice site for an intron and thus explained the abnormal mRNAs that retain 24 bases of the 3-prime terminus of intron 12. The intron 12 and flanking exons 12 and 13 sequences were normal in the other allele. The other mutant allele was thought to be of an mRNA-negative type. The same mutation was found in a 35-year-old Japanese man with manifestations of juvenile Sandhoff disease: progressive neurogenic muscular atrophy, cerebellar ataxia, and mental deterioration beginning at age 10. Dlott et al. (1990) found the same mutation in cells from 2 juvenile Sandhoff disease patients and a third, asymptomatic individual.

Phenotypic Data

back to top
Remarks Juvenile; cerebellar ataxia; severe mental retardation; deficient hexosaminidase A and B; same patient as GM02144; normal level of fibro preBchain mRNA; 3% of normal fibro Hex A activity; Hex B gene shows no gross abnormalities; point mutation in 1 beta-chain allele (c.1509-26G>A), resulting in an a 24-base insertion between exons 12 and 13 in cDNA. Mutation in the other allele is unknown.

Publications

back to top
Nakano T, Suzuki K, Genetic cause of a juvenile form of Sandhoff disease. Abnormal splicing of beta-hexosaminidase beta chain gene transcript due to a point mutation within intron 12. J Biol Chem264:5155-8 1989
PubMed ID: 2522450
 
O'Dowd BF, Klavins MH, Willard HF, Gravel R, Lowden JA, Mahuran DJ, Molecular heterogeneity in the infantile and juvenile forms of Sandhoff disease (O-variant GM2 gangliosidosis). J Biol Chem261:12680-5 1986
PubMed ID: 3017984
 
Hohmann P, Species- and cell-specific expression of H1 histones in tissue culture cells. Arch Biochem Biophys205:198-209 1980
PubMed ID: 7447476

External Links

back to top
dbSNP dbSNP ID: 15216
NCBI GTR 268800 SANDHOFF DISEASE
OMIM 268800 SANDHOFF DISEASE
Omim Description GM2-GANGLIOSIDOSIS, TYPE II
  HEXOSAMINIDASES A AND B DEFICIENCY; HEXB-HEXOSAMINIDASE B, INCLUDED; HEXB, INCLUDED
  SANDHOFF DISEASE
  SANDHOFF DISEASE, ADULT TYPE, INCLUDED
  SANDHOFF DISEASE, INFANTILE TYPE, INCLUDED
  SANDHOFF DISEASE, JUVENILE TYPE, INCLUDED

Culture Protocols

back to top
Passage Frozen 5
Split Ratio 1:3
Temperature 37 C
Percent CO2 5%
Percent O2 3%
Medium Eagles Minimum Essential Medium with Earle's salts:Dulbecco's modified MEM with 2mM L-glutamine or equivalent
Serum 15% fetal bovine serum Not inactivated
Supplement -
Pricing
Commercial/For-profit:
$373.00USD
Academic/Non-profit/Government:
$216.00USD
Add to Cart
How to Order
  • Ordering Instructions
  • MTA / Assurance Form
  • Statement of Research Intent Form
Related Products
Same Family
  • 432
Miscellaneous
  • DNA on Demand
  • Custom Services

Our mission is to prevent and cure disease through biomedical research.

CONTACT US

CUSTOMER SERVICE
customerservice@coriell.org (800) 752-3805 • (856) 757-4848
Subscribe to our newsletter here

Coriell Institute for Medical Research
403 Haddon Avenue Camden, NJ 08103, USA (856) 966-7377

Ⓒ 2025 Coriell Institute. All rights reserved.

  • Facebook
  • Linkedin
  • Youtube